Agilent Technologies Offers First FFPE Kit for Oligo CGH Microarrays

SANTA CLARA, Calif., and AMSTERDAM, The Netherlands, Aug. 15, 2007 — Agilent Technologies Inc. (NYSE: A) and Kreatech Biotechnology BV today announced the availability of labeling kits that, for the first time, enable oligo microarray comparative genomic hybridization (CGH) analysis of DNA from formalin-fixed paraffin-embedded (FFPE) tissue samples.

Source Agilent